PKC-beta inhibitors (Japan Tobacco)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePKC-beta inhibitors (Japan Tobacco)
Drug Alias Nameprotein kinase C-beta inhibitors (Japan Tobacco)JTT-010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C beta inhibitors
TargetsProtein kinase C beta
Therapy Area/IndicationsDiabetes ComplicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJapan Tobacco Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJapan Tobacco Inc
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A